retatrutide trial news Lilly's Scores Triple Triumph With 26% Weight Loss, But New Safety Signal Emerges Eli Lilly's Retatrutide Phase 3

In 2025, 24.3% of Americans who had ever taken a GLP-1 reported using a compounded version, and 11% of consumers obtained their GLP-1 medications through online platforms

(1) Youre also helping to feed your good gut bacteria and support a healthy microbiome, which is essential for metabolism and weight management

doi:10.1111/ijcp.12361

40 KimuraR.OkouchiM.FujiokaH.IchiyanagiA.RyugeF.MizunoT.et al (2009)

These are the behaviors that stabilize weight once medication decreases or stops

It slows down gastric emptyingkeeping food in your stomach longerand signals the satiety centers of the brain to stop cravings and intrusive thoughts about food